Oncology letters

Keyphrases

Publications

volume 28, number 4, 2024

Yu-Jie Guo, Meng-Xue Ma, Tian Tian, Jing-Nan Zhang, Xiao-Nan Guo, Shukai Qiao
Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement t(8;13)(p11;q12): A case report and literature review. Oncology letters 28 (4) (2024)
Ang Li, Fasheng Li, Zhipeng Ma, Yutao Pang, Boyun Deng, Zhan He, Zhu Liang, Jie Chen
Pembrolizumab therapy in a patient with NSCLC and bullous pemphigoid: A case report. Oncology letters 28 (4) (2024)
Chunyan Wu, Wei Ge, Yun Wu
Mucosa‑associated lymphoid tissue lymphoma translocation protein 1 inhibitor, MI‑2, attenuates non‑small cell lung cancer cell proliferation, migration and invasion, and promotes apoptosis by suppressing the JNK/c‑JUN pathway. Oncology letters 28 (4) (2024)
Chang Zhang, Limei Zhang, Qiyuan Huang, Siyuan Jiang, Tao Peng, Shu Wang, Xuehu Xu
Diagnostic and screening potential of plasma exosome miR‑99b‑5p and its combination with other miRNAs for colorectal cancer. Oncology letters 28 (4) (2024)
Megumi Kikuchi, Satoru Monzen, Mai Horikoshi, Shuri Tsuda, Yota Tatara, Andrzej Wojcik, Yasushi Mariya
Characteristics of sphingomyelin metabolism in the MCF7 and BT474 radiotherapy‑resistant HER2‑positive breast cancer cell lines. Oncology letters 28 (4) (2024)

volume 28, number 5, 2024

Mingming Jiang, Linyun Li, Hongjie Liu, Hua Xie
Male breast cancer metastasising to the liver: A case report. Oncology letters 28 (5) (2024)
Ning Du, Xuelin Zhao, Jiawei Du, Ji-Guo Yu, Meng Xu, Yafeng Song
Functional rehabilitation and long‑term efficacy of rotationplasty in pediatrics: A retrospective study. Oncology letters 28 (5) (2024)
Huili Pan, Zhiyan Luo, Feng Lin, Jing Zhang, Ting Xiong, Yurong Hong, Bohao Sun, Yan Yang
FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis. Oncology letters 28 (5) (2024)
Liang Zhang, Zhong Lv, Qin-Yu Xu, Bin Wu
TREM2 promotes the proliferation and invasion of renal cell carcinoma cells by inhibiting the P53 signaling pathway. Oncology letters 28 (5) (2024)
Yingying Fan, Ying He, Liang Sun, Tianmin Liu, Yangmei Shen
Mesonephric adenocarcinoma of the uterine cervix with a prominent spindle cell component. Oncology letters 28 (5) (2024)
Tabata Carolina Faria Nascimento de Assis, Liane Rapatoni, Flavio Nogueira Segato, Barbhara Thais Maciel Pontes, Valdair Francisco Muglia, Miguel Moyses Neto, Elen Almeida Romao
Effective treatment of collecting duct carcinoma in a recipient of a kidney transplant: A case report. Oncology letters 28 (5) (2024)
Eijiro Uchikura, Takeshi Fukuda, Tomoki Sengiku, Takuya Noda, Yuichiro Awazu, Takuma Wada, Reiko Tasaka, Makoto Yamauchi, Tomoyo Yasui, Toshiyuki Sumi
Role of Fyn expression in predicting the sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma. Oncology letters 28 (5) (2024)
Junichi Ikeda, Chisato Ohe, Takashi Yoshida, Takahiro Nakamoto, Ryoichi Saito, Koji Tsuta, Hidefumi Kinoshita
Prognostic impact of lymph node invasion levels in patients with bladder cancer undergoing radical cystectomy and pelvic lymphadenectomy. Oncology letters 28 (5) (2024)
Yi-Cheng Jiang, Jing-Jing Yang, Hai-Tian Zhang, Rui Zhuo, Sebastian De La Roche, Luz Angela Torres-De La Roche, Rudy Leon De Wilde, Jie Dong
First‑line endocrine therapy for hormone receptor positive and HER‑2 negative metastatic breast cancer: A Bayesian network meta‑analysis. Oncology letters 28 (5) (2024)
Shuai Han, Xin Song, Jialiang Liu, Jingfen Zhou, Zhipeng Wu, Haihan Song, Jun Tao, Jian Wang
Analysis of metastasis‑related risk factors and clinical relevance in adult soft‑tissue sarcoma. Oncology letters 28 (5) (2024)
Bo Liu, Xiandong Song, Zhaowei Yan, Hao Yang, Yingchao Shi, Jintao Wu
[Retracted] MicroRNA‑525 enhances chondrosarcoma malignancy by targeting F‑spondin 1. Oncology letters 28 (5) (2024)
Rie Mizumoto, Norikatsu Miyoshi, Rie Hayashi, Shinya Kato, Soichiro Minami, Mitsunobu Takeda, Yuki Sekido, Tsuyoshi Hata, Atsushi Hamabe, Takayuki Ogino, Mitsuyoshi Tei, Yoshinori Kagawa, Mamoru Uemura, Yuichiro Doki, Hidetoshi Eguchi
Usefulness of a powered circular stapler compared with a manual circular stapler in patients undergoing colorectal cancer surgery: A retrospective cohort study and systematic review. Oncology letters 28 (5) (2024)
Minghe Wang, Xuejing Wang, Yanqi Wang, Yikuo Gai, Jingran Ye, Xinyan Xu, Xue You
Advances in the study of the mechanism of action of miR‑22 in liver lesions (Review). Oncology letters 28 (5) (2024)
Zhengrong Ou, Shoushuo Fu, Jian Yi, Jingxuan Huang, Weidong Zhu
Diagnostic value of expressions of cancer stem cell markers for adverse outcomes of hepatocellular carcinoma and their associations with prognosis: A Bayesian network meta‑analysis. Oncology letters 28 (5) (2024)
Yangyang Huang, Rui Song, Tingting Qin, Menglin Yang, Zongwen Liu
Clinical evaluation of the convolutional neural network‑based automatic delineation tool in determining the clinical target volume and organs at risk in rectal cancer radiotherapy. Oncology letters 28 (5) (2024)
Jong Jin Sung, Ae Ri Ahn, Ho Sung Park, Kyu Yun Jang, Woo Sung Moon, Ju-Hyung Lee, Kyoung Min Kim, Myoung Ja Chung
Incidence and pattern of second primary cancer in patients diagnosed with primary cancer. Oncology letters 28 (5) (2024)
Jing Dong, Maoxiu Wang, Donghua Ni, Lixin Zhang, Wen Wang, Xiujuan Cui, Shijie Fu, Shujuan Yao
[Retracted] MicroRNA‑217 functions as a tumor suppressor in cervical cancer cells through targeting Rho‑associated protein kinase 1. Oncology letters 28 (5) (2024)
Jing Wang, Qianqian Xu, Jiangbo Yu, Aotian Xu, Lizheng Yu, Zhenggang Chen, Yang Cao, Rongtao Yuan, Zhongjie Yu
SCGB1A1 as a novel biomarker and promising therapeutic target for the management of HNSCC. Oncology letters 28 (5) (2024)
Zhaojun Yu, Huanhuan Deng, Haichao Chao, Zhen Song, Tao Zeng
Construction of a cuproptosis‑related lncRNA signature to predict biochemical recurrence of prostate cancer. Oncology letters 28 (5) (2024)
Huijuan Qian, Si Li, Ziyun Hu
Association between renal dysfunction and outcomes of lung cancer: A systematic review and meta‑analysis. Oncology letters 28 (5) (2024)
Yu Wang, Qinqin Sun, Zhijian Li, Fei Leng, Xuelian Han, Qiqi Su, Sheng Su
Malignant melanoma complicated with cataract and secondary glaucoma: A case report. Oncology letters 28 (5) (2024)
Yawen Luo, Lin Lin, Chen Shufeng, Chun Liu, Zhuanghua Li, Kejun Liu
Osimertinib treatment response in a patient with lung adenocarcinoma harboring two rare EGFR mutations: A case report. Oncology letters 28 (5) (2024)
Huina Lv, Yanyan Hong, Yuting Zhang, Siyu Li, Bingbing Li, Mingjun Zhang
Efficacy and safety of nanoparticle albumin‑bound paclitaxel compared with solvent‑based paclitaxel in adjuvant therapy for breast cancer: A retrospective study. Oncology letters 28 (5) (2024)
Ke Sun, Mengdi Zhu, Guodong Chen, Bin Liu
Neoadjuvant chemotherapy for primary invasive ductal carcinoma of the nipple: A case report. Oncology letters 28 (5) (2024)
Zifeng Liu, Mei Ren, Shasha Jia, Sen Qiao, Dong Yang
Association between tumor necrosis factor receptor 2 and progression and poor prognosis of tumor stage 2‑3 esophageal squamous cell carcinoma and stratified analysis. Oncology letters 28 (5) (2024)
Valentina Kottmann, Elena Kolpeja, Greta Baumkötter, Franziska Clauder, Ansgar Bokel, Franz Paul Armbruster, Philipp Drees, Erol Gercek, Ulrike Ritz
Bone sialoprotein stimulates cancer cell adhesion through the RGD motif and the αvβ3 and αvβ5 integrin receptors. Oncology letters 28 (5) (2024)
Meifang Li, Cheng Lin, Jinghui Lin, Shijie Chen, Lihong Weng, Zhiyong He
Efficacy analysis of immunotherapy‑based combinations for patients with EGFR‑mutant advanced non‑small cell lung cancer after TKI failure. Oncology letters 28 (5) (2024)
Bonney Lee James, Shaesta Naseem Zaidi, Naveen Bs, Vidya Bhushan R, Yogesh Dokhe, Vivek Shetty, Vijay Pillai, Moni Abraham Kuriakose, Amritha Suresh
Reference gene evaluation for normalization of gene expression studies with lymph tissue and node‑derived stromal cells of patients with oral squamous cell carcinoma. Oncology letters 28 (5) (2024)
Hongmei Ding, Juan Wang, Xiaoyu Zhao, Shi Xiu, Honghong Cai, Jingjing Ma, Li Fu, Jinhua Zhou, Fangrong Shen, Hong Zhang, Youguo Chen, Bingyan Li, Jing Yan
Combination of circulating tumor cells, lncRNAs and DNA methylation for the diagnosis of endometrial carcinoma. Oncology letters 28 (5) (2024)
Wen Wang, Jing Dong, Maoxiu Wang, Shujuan Yao, Xiangyu Tian, Xiujuan Cui, Shijie Fu, Shiqian Zhang
[Retracted] miR‑148a‑3p suppresses epithelial ovarian cancer progression primarily by targeting c‑Met. Oncology letters 28 (5) (2024)
Danqi Liu, Haima Li, Jia Ouyang
Roles of DEPDC1 in various types of cancer (Review). Oncology letters 28 (5) (2024)
Wei Sun, Qihong Hu, Zhi Liu, Qing Zhang, Jian Wang
Analysis of the clonal origin and differences in the biological behavior of multifocal papillary thyroid carcinoma. Oncology letters 28 (5) (2024)
Yao Xiao, Xinlong Chen, Wancheng Li, Xin Li, Wence Zhou
Impact of ACEI/ARB use on the survival of hypertensive patients with cancer: A meta‑analysis. Oncology letters 28 (5) (2024)
Jared E Limones-Gonzalez, Perla Aguilar Esquivel, Karla Vazquez-Santillan, Rosario Castro-Oropeza, Floria Lizarraga, Vilma Maldonado, Jorge Melendez-Zajgla, Patricia Piña-Sanchez, Gretel Mendoza-Almanza
Changes in the molecular nodes of the Notch and NRF2 pathways in cervical cancer tissues from the precursor stages to invasive carcinoma. Oncology letters 28 (5) (2024)
Nannan Liu, Shanshan Liu, Xueshuang Zhang, Wenzhu Tian, Heqiang Jia, Xin Ye, Xiaoyu Yan, Chunyan Yu, Huimei Yu
Zinc finger domain of p62/SQSTM1 is involved in the necroptosis of human cisplatin‑resistant ovarian cancer cells treated with sulfasalazine. Oncology letters 28 (5) (2024)
Shinichiro Yamada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Hiroki Teraoku, Yuhei Waki, Chiharu Nakasu, Takayuki Noma, Mitsuo Shimada
Evaluation of malignancy in gallbladder tumors using the apparent diffusion coefficient obtained by diffusion‑weighted MRI. Oncology letters 28 (5) (2024)
Ke Zhao, Min Hu, Xiaowen Li, Runfeng Yang, Yi Huang
Clinicopathological features of endometriosis‑associated adenocarcinoma of the rectum: A report of two cases. Oncology letters 28 (5) (2024)
Qing Ma, Bo Song, Kun Cao, Xiaoyun She, Wei Chen, Weijun Wang, Huiying Huang
Malignant melanoma meningeal metastasis with concurrent hemorrhagic cerebrospinal fluid: A case report. Oncology letters 28 (5) (2024)
Lifeng Weng
Role of ultrasound‑guided fine‑needle aspiration cytology combined with thyroid peroxidase and thyroglobulin antibodies in evaluating cervical lymph node metastasis in thyroid cancer. Oncology letters 28 (5) (2024)
Ertugrul Bayram, Umur Anil Pehlivan, Kivilcim Eren Erdogan, Mehmet Turker, Hafize Yalniz, Semra Paydas
Coexistence of acute severe leukocytosis and anaplastic lymphoma kinase‑positive histiocytic sarcoma, a rare entity with an unusual presentation: A case report. Oncology letters 28 (5) (2024)
Ling Xu, Qiansheng Wu, Kai Zhao, Xiangyu Li, Wei Yao
Prognostic prediction signature and molecular subtype for liver cancer: A CTC/CTM‑related gene prediction model and independent external validation. Oncology letters 28 (5) (2024)
Wanting Xiao, Chaoyang Xu
Cystine/cysteine metabolism regulates the progression and response to treatment of triple‑negative breast cancer (Review). Oncology letters 28 (5) (2024)
Weronika Kawecka, Aneta Adamiak-Godlewska, Dorota Lewkowicz, Karolina Urbańska, Andrzej Semczuk
Diagnostic difficulties in the differentiation between an ovarian metastatic low‑grade appendiceal mucinous neoplasm and primary ovarian mucinous cancer: A case report and literature review. Oncology letters 28 (5) (2024)
Ning Lyu, Jiawen Wu, Yiqin Dai, Yidan Fan, Zhaoyuan Lyu, Jiayu Gu, Jingyi Cheng, Jianjiang Xu
Identification of feature genes and molecular mechanisms involved in cell communication in uveal melanoma through analysis of single‑cell sequencing data. Oncology letters 28 (5) (2024)
Zhuo-Ran Li, Yong Jiang, Jian-Zhong Hu, Yang Chen, Quan-Zhong Liu
[Retracted] SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1‑mediated PI3K/AKT signaling pathway. Oncology letters 28 (5) (2024)